Although not initially thought to be directly associated with epigenetics, the tricarboxylic acid cycle enzyme Isocitrate Dehydrogenase (IDH), when mutated in cancer, has been shown to affect different epigenetic mechanisms. Here, IDH2 is linked to cancer.